Effect of remdesivir vs standard care on clinical status of patients with moderate COVID-19

(JAMA Network) This open-label randomized trial compares the effect of remdesivir (5 or 10 days) compared with standard care on clinical status 11 days after treatment initiation among patients with confirmed SARS-CoV-2 infection hospitalized with moderate pneumonia.